Filing Details
- Accession Number:
- 0001764013-22-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 10:53:30
- Reporting Period:
- 2022-01-07
- Accepted Time:
- 2022-01-11 10:53:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1764013 | Immunovant Inc. | IMVT | Biological Products, (No Disgnostic Substances) (2836) | 832771572 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1883766 | Renee Eva Barnett | C/O Immunovant, Inc. 320 W 37Th Street, 6Th Floor New York NY 10018 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-07 | 29,959 | $7.25 | 172,541 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On October 4, 2021, the holder was granted 59,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 5, 2021. These RSUs vested in their entirety on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.
Billionaire Hedge Funds
